CRISPR Therapeutics (CRSP) Surges 8.7%: Is This an Indication of Further Gains?

CRISPR Therapeutics AG (CRSP) shares soared 8.7% in the last trading session to close at $76.78. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the stock's 31.5% gain over the past four weeks.This rise in share price reflects growing investor optimism around CRISPR gene-editing technology. CRISPR Therapeutics remains the only company to have secured regulatory approval for a therapy based on this platform. In collaboration with Vertex Pharm ...